R. Koike

发表

U-shaped association between abnormal serum uric acid levels and COVID-19 severity: reports from the Japan COVID-19 Task Force

Y. Okada, S. Miyano, S. Imoto, 2022, International Journal of Infectious Diseases.

DOCK2 is involved in the host genetics and biology of severe COVID-19

M. Kanai, Y. Kamatani, Y. Okada, 2022, Nature.

Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics

Y. Okada, S. Miyano, S. Imoto, 2022, BMC Infectious Diseases.

Impact of upper and lower respiratory symptoms on COVID-19 outcomes: a multicenter retrospective cohort study

Y. Okada, S. Miyano, S. Imoto, 2022, Respiratory Research.

Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID‐19 task force

Y. Okada, S. Miyano, S. Imoto, 2022, Diabetes, obesity & metabolism.

Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force

M. Kanai, Y. Okada, S. Fuke, 2022, BMC infectious diseases.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Radiation myelopathy: a clinicopathological study with special reference to correlation between MRI findings and neuropathology

K. Ikeda, K. Tsuchiya, T. Matsunaga, 1995, Journal of the Neurological Sciences.

Impact of accumulative smoking exposure and chronic obstructive pulmonary disease on COVID-19 outcomes: report based on findings from the Japan COVID-19 task force

S. Miyano, S. Imoto, S. Ogawa, 2022, International Journal of Infectious Diseases.

Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study

S. Miyano, S. Imoto, S. Ogawa, 2023, BMC Pulmonary Medicine.

A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)

T. Takahara, H. Yaegashi, Y. Yoshioka, 2023, BMC Urology.

Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19

Y. Okada, S. Miyano, S. Imoto, 2023, BMJ Open Respiratory Research.

Use of the neutrophil-to-lymphocyte ratio and an oxygen requirement to predict disease severity in patients with COVID-19

S. Miyano, S. Imoto, S. Ogawa, 2023, Respiratory Investigation.

Diagnostic significance of secondary bacteremia in patients with COVID-19

S. Miyano, S. Imoto, S. Ogawa, 2023, Journal of Infection and Chemotherapy.

Lymphoproliferative disorder risk after methotrexate treatment for rheumatoid arthritis

Keisuke Tanaka, C. Sakashita, Kouhei Yamamoto, 2023, Cancer science.

Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan

R. Saito, Y. Takahashi, R. Koike, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

M. Kanai, Y. Okada, S. Fuke, 2023, Nature Genetics.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave – a nationwide study in Japan

Y. Okada, S. Miyano, S. Imoto, 2023, International Journal of Infectious Diseases.

Clinical utilization of artificial intelligence-based COVID-19 pneumonia quantification using chest computed tomography – a multicenter retrospective cohort study in Japan

S. Imoto, T. Hirai, M. Ishii, 2023, Respiratory Research.

Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force

S. Miyano, S. Imoto, S. Ogawa, 2023, Open forum infectious diseases.

Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan

S. Imoto, T. Hirai, N. Harada, 2024, BMJ open respiratory research.

Association between ABO blood group/genotype and COVID-19 in a Japanese population

S. Miyano, S. Imoto, S. Ogawa, 2023, Annals of Hematology.

Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2

T. Hosoya, A. Ainai, R. Koike, 2024, Cytokine.

CT-derived vertebral bone mineral density is a useful biomarker to predict COVID-19 outcome.

S. Imoto, T. Hirai, N. Harada, 2024, Bone.

Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching

T. Hosoya, T. Tateishi, T. Mitsumura, 2023, Frontiers in immunology.

Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan

R. Saito, Y. Takahashi, R. Koike, 2014, European Journal of Clinical Microbiology & Infectious Diseases.

Novel insights into genetic characteristics of blaGES-encoding plasmids from hospital sewage

R. Saito, Yoshiaki Gu, Y. Nukui, 2023, Frontiers in microbiology.

Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial

S. Kusuda, Akinari Hinoki, T. Hatata, 2023, The Lancet regional health. Western Pacific.

Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precision

S. Imoto, Akinori Kimura, R. Edahiro, 2023, NAR Genomics and Bioinformatics.